Stems cells, big data and compendium-based analyses for identifying cell types, signalling pathways and gene...

Area of Science:

• Biotechnology
• Genomics
• Proteomics

Background:

• Human pluripotent stem cells and organoids offer a valuable in vitro source for studying human cell types and tissues.
• Understanding molecular mechanisms of normal and disease development is crucial for identifying new therapeutic targets.

Purpose of the Study:

• To review how compendium-based analyses of 'omics' data can support stem cell technology applications in developing new therapies.
• To highlight the role of molecular characterization in defining cell identity, signaling pathways, and gene networks.

Main Methods:

• Utilizing big data ('omics') techniques like transcriptomics and proteomics for cell and tissue characterization.
• Applying bioinformatics methods, including compendium-based analyses, to interpret large-scale gene and protein profiles.
• Comparing sample profiles against reference compendia to understand biological states.

Main Results:

• Compendium-based analyses facilitate robust definition of differentiated stem cell identity.
• These methods aid in elucidating complex signaling pathways and target gene networks in both normal and diseased states.
• The approach supports the application of stem cell technology for novel therapy development.

Conclusions:

• Detailed molecular characterization using 'omics' and bioinformatics is key to advancing stem cell-based therapies.
• Compendium-based analysis provides a powerful framework for drug and cell therapy target discovery.
• This strategy enhances the translation of stem cell research into clinical applications.